Emerging treatments in the management of psoriasis: biological targeting with ustekinumab
Marina Papoutsaki, Antonio Costanzo, Sergio ChimentiDepartment of Dermatology, University of Rome, “Tor vergata”, Rome, ItalyAbstract: Psoriasis is a chronic, genetically determined, immune-mediated, inflammatory skin disease affecting approximately 2% to 3% of Caucasian...
Main Authors: | Marina Papoutsaki, Antonio Costanzo, Sergio Chimenti |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2009-05-01
|
Series: | Clinical, Cosmetic and Investigational Dermatology |
Online Access: | http://www.dovepress.com/emerging-treatments-in-the-management-of-psoriasis-biological-targetin-a3159 |
Similar Items
-
Ustekinumab Treatment of Erythrodermic Psoriasis Occurring after Physical Stress: A Report of Two Cases
by: Rosita Saraceno, et al.
Published: (2013-09-01) -
Ustekinumab for the treatment of moderate to severe psoriasis
by: E Gospodarevskaya, et al.
Published: (2009-10-01) -
Ixekizumab and ustekinumab in psoriasis: post-hoc comparison of onset and duration of treatment response
by: Marc Radtke, et al.
Published: (2022-02-01) -
Comparative assessment of biologics in treatment of psoriasis: drug design and clinical effectiveness of ustekinumab
by: Ignacio Garcia-Valladares, et al.
Published: (2011-01-01) -
Patient considerations and targeted therapies in the management of psoriasis in Chinese patients: role of ustekinumab
by: Zhao Y, et al.
Published: (2014-06-01)